Company News for Sep 20, 2024

• Progyny Inc.’s (PGNY) shares plunged 32.7% after the company lost one of its significant clients, which accounted 12-13% Progyny’s revenues in the past 12 months.
• Shares of Edgewise Therapeutics Inc. (EWTX) soared 54.7% the company announced positive top-line trial data for a heart disease treatment.
• Shares of FactSet Research Systems Inc. (FDS) surged 5.1% after posting fourth-quarter fiscal 2024 adjusted earnings per share of $3.74, surpassing the Zacks Consensus Estimate of $3.60.
• Steelcase Inc.’s (SCS) shares tumbled 5.7% after reporting second-quarter fiscal 2025 adjusted earnings per share of $0.39, missing the Zacks Consensus Estimate of $0.37.

5 Stocks Set to Double

Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 5 Stocks Set to Double. Click to get this free report

FactSet Research Systems Inc. (FDS) : Free Stock Analysis Report

Steelcase Inc. (SCS) : Free Stock Analysis Report

Progyny, Inc. (PGNY) : Free Stock Analysis Report

Edgewise Therapeutics, Inc. (EWTX) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.